Flash FinanceUS
Market open S&P 5007,376.86+0.31% Nasdaq24,579.42+1.09% Dow 3051,285.73-0.46% Russell 20002,754.11+0.89% Nasdaq-10026,989.99+1.35% MidCap 4003,602.50+0.56% SmallCap 6001,673.98+0.05% VIX25.64-9.01% 10Y Yield4.86+0.45% Close of Nov 06, 2026
AI brief of an SEC Form 8-K · Autonomix Medical, Inc. (AMIX)

Autonomix Medical adds former Medtronic regulatory counsel Sandra Kalter to board

Neutral Impact 2 of 5 leadership Written later

Autonomix Medical increased its Board from five to six members and appointed Sandra Kalter, a former Medtronic Vice-President and Chief Regulatory Counsel, as an independent director effective immediately. The filing says she has not been named to any Board committee yet, and the appointment is presented as adding medical device regulatory and industry experience.

Key points

  • Board size increased from five to six members; appointment made September 14, 2026, effective immediately
  • Kalter served at Medtronic plc in senior roles, most recently as Vice-President and Chief Regulatory Counsel from May 2011 to January 2025
  • No Board committee appointments at this time; she will join the standard non-employee director compensation program
  • Press release (Exhibit 99.1) dated September 16, 2026 announces the appointment

The filing

CompanyAutonomix Medical, Inc. (AMIX)
Form8-K, current report
Filed with the SECSep 16, 2026, 8:35 AM ET
Accession number0001437749-26-030505

Items reported: 5.02 Director / Officer Change

Read the filing on SEC.gov ↗

Written by AI on Nov 9, 2026, 8:38 AM ET, from this filing only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on September 16, 2026.

Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.